News archive

2012

X

News archive | Stryker

Products

听 听 听
11/15/2012 Stryker听announces the launch of a mini version of its Mobile Training Center (MTC mini) at The Seventh International Congress of Chinese Orthopaedic Association taking place in Beijing, China. Stryker successfully launched the first China Mobile Training Center (MTC) last year in order to provide medical technology training solutions to healthcare providers. The new MTC mini will broaden access into more cities in China and increase training opportunities for customers. The MTC mini will feature the latest Stryker products and instrumentation and enables hands-on practices and procedural training.
11/8/2012 Stryker Sustainability Solutions President, Brian White, discusses听how the ideal reprocessor is the one that operates within a framework that emphasizes education, promotion, integration, and continuous supporter.听
11/8/2012 Stryker announces the global commercial launch of the new Trevo庐 ProVue鈩 Retriever. The World鈥檚 First Fully Visible Stent Retriever Device to Treat Acute Ischemic Stroke Expands Stryker鈥檚 Commitment to Complete Stroke Care. The Trevo ProVue Retriever is the first clot removal device fully visible during the procedure for precise positioning within the clot and optimized clot retrieval in patients experiencing acute ischemic stroke. Previous technology only provided visibility to the edges of the device. 鈥淭revo ProVue Retriever鈥檚 full visibility provides a significant clinical benefit.鈥 said Professor Liebig, M.D., Head of Neuroradiology, University Hospital of Cologne in Cologne, Germany. 鈥淚 am impressed with how full device visibility provides more information during the procedure to quickly and easily position the device and enables real-time feedback for a new level of confidence to open blood vessels.鈥澨
11/1/2012 Stryker announces the closing of its previously announced acquisition of privately-held Surpass Medical, Ltd. (Surpass). Surpass is developing and commercializing the NeuroEndoGraft family of next-generation flow diversion stent technology to treat brain aneurysms using a unique mesh design and delivery system. "With the acquisition of Surpass Medical we are continuing to expand our global product portfolio in the fast growing and highly innovative neurovascular market by offering patients and caregivers differentiated products focused on Complete Stroke Care," said Kevin A. Lobo, President and Chief Executive Officer.听听听 听
10/16/2012 Stryker announced听a definitive agreement to acquire privately-held Surpass Medical, Ltd.听Headquartered in Tel Aviv, Israel, with manufacturing and R&D in Miramar, Florida, Surpass is developing and commercializing next-generation flow diversion stent technology to treat brain aneurysms using a unique mesh design and delivery system. Surpass' key product, the NeuroEndoGraft family of flow diverters, is designed to redirect blood flow away from an aneurysm, allowing a stable clot to be formed within the aneurysm pouch.听听
10/4/2012 Stryker announced听that it has launched a revolutionary computer assisted surgery system, Stryker ADAPT鈩 for the Gamma3鈩 Locking Nail System. Gamma3 nails are used to treat hip fractures, which are breaks in the upper end of the femur (the thighbone). "We are pleased to offer the ADAPT/Gamma3 technology which assists surgeons to more accurately position the lag screw, with no significant difference in procedure time," said Jim Bruty, Senior Director of Marketing, Stryker Navigation. "In addition, the number of x-ray images taken during the procedure can be reduced, which could potentially reduce the radiation exposure for the patient and the operating room staff."听听 听
9/19/2012 Doctors have a new device option to treat stroke patients. At Capital Health in New Jersey, they are using one called Trevo from Stryker. Doctors thread a catheter right to the clot, and unlike other similar devices, this one restores blood flow to the brain right away. Within hours after treatment, this patient was able to move and talk..watch the video.听
8/26/2012 Read about the study of the randomized trial that was held between Feb 3, 2011, and Dec 1, 2011, where we randomly assigned 88 patients to the Trevo Retriever group and 90 patients to Merci Retriever group. 76 (86%) patients in the Trevo group and 54 (60%) in the Merci group met the primary endpoint after the assigned device was used (odds ratio 4鈥22, 95% CI 2鈥01鈥8鈥86; psuperiority<0鈥0001). Incidence of the primary safety endpoint did not differ between groups (13 [15%] patients in the Trevo group vs 21 [23%] in the Merci group; p=0鈥1826).听 听
8/13/2012 Next generation clot removal technology provides physicians with a powerful new tool to treat acute ischemic stroke. Stryker Neurovascular's Trevo庐 Pro Retriever has been granted 510(k) market clearance by the U.S. Food and Drug Administration.听
8/10/2012 Capital Health Regional Medical Center became the first hospital in the country to treat a stroke patient using Trevo鈩 following its approval by the FDA. The device was used by Capital Health cerebrovascular and endovascular neurosurgeon, Dr. Erol Veznedaroglu, and restores blood flow to the brain faster.
4/18/2012 Many hospitals have recognized that reprocessing single-use devices (SUDs) is a proven solution with tangible fiscal and environmental benefits to help address the resource management challenges they face. Reprocessing programs have become a favored practice among leading hospitals across the nation, including all 17 U.S. News & World Report "Honor Roll" hospitals. However, there is more to reprocessing than simply having a program in place. One of the most critical aspects of a reprocessing program is selecting the right partner.听
4/17/2012 听 Stryker's Sustainability Solutions division recently announced the launch of Restep, our new deep vein thrombosis (DVT) prevention system. The system is used for the prevention of deep vein thrombosis in patients that are at risk for clot formation.
3/11/2012 A sampling of Stryker鈥檚 EMS products was recently featured at the first ever Cape & Coast Prehospital Conference in Marion, Massachusetts, U.S. The conference gave vendors and recruiters in the medical, police, fire, security and military industries a chance to highlight the opportunities found in the region鈥檚 emergency medical care industry.
3/7/2012 Stryker announced the release of System 7 鈥 the next generation of heavy duty surgical power tools for use in total joint procedures, such as hip and knee replacements. System 7 offers the latest in advanced cutting technology, resulting in the most dependable and highest performing power tool system ever from Stryker. Stryker was the first to market with cordless heavy duty power tools in 1982, and has built a 30 year legacy of quality and innovation, resulting in the introduction of System 7 鈥 a precise and reliable solution for surgeons and hospitals.
3/5/2012

In the news

听 听 听
11/20/2012 Two Stryker facilities were recently awarded the BREEAM certification. 九色视频 Venlo distribution center in the Netherlands received a "very good" rating, while our new Stryker U.K. facility in Newbury received an "excellent" rating. BREEAM is the world's foremost environmental assessment method and rating system for buildings. BREEAM sets the standard for best practice in sustainable building design, construction and operation and has become one of the most comprehensive and widely recognized measures of a building's environmental performance. A BREEAM assessment uses recognized measures of performance, which are set against established benchmarks, to evaluate a building鈥檚 specification, design, construction and use. The measures used represent a broad range of categories and criteria from energy to ecology. They include aspects related to energy and water use, the internal environment (health and well-being), pollution, transport, materials, waste, ecology and management processes.
11/20/2012 Stryker named as major corporate partner to Hurricane Sandy Relief Efforts. The Red Cross of West Michigan is extremely grateful for the generosity of these businesses that are based in our region,鈥 said Cheryl Bremer, Regional CEO of the Red Cross of West Michigan. 鈥淭heir support is critical to our ability to provide food, shelter, relief supplies and comfort for thousands of people who have been impacted by Hurricane Sandy and other related storms.鈥
10/1/2012 Stryker Corporation's (NYSE:SYK) Board of Directors announced today that Kevin A. Lobo has been named the Company's President and Chief Executive Officer, effective immediately. He has also been named to the Company's Board of Directors. Mr. Lobo joined Stryker in April 2011, and was most recently Group President of Stryker Orthopaedics. Orthopaedics includes the Company's Reconstructive, Osteosynthesis, Joint Preservation, Orthobiologics and Performance Solutions businesses.听 听
3/19/2012 Pioneer Awards will be presented at The Gala of Brain Mapping Foundation on June 1, 2012 in Toronto. Kevin Lobo, Orthopedics Group President, will be accepting a Pioneer in Technology Development award from the Society on behalf of Stryker, who has contributed to the introduction of new devices, technologies and significantly contributed to therapies of neurological disorders. The Pioneer in Technology Award is presented to trailblazing companies and their CEOs/presidents who have facilitated the development of pioneering technologies through interdisciplinary approaches that have impacted diagnostics, treatment, and healthcare delivery in unprecedented ways.
1/10/2012 In this live interview from the J.P. Morgan Healthcare Conference in San Francisco, Chairman, President and CEO Steve MacMillan discusses how the Patient Protection and Affordable Care Act鈥檚 new 2.3 percent tax on medical device makers is impacting business.
1/5/2012 Gallup Management Journal published an article which highlights the change in culture at Stryker鈥檚 Orthopaedics division in Mahwah, NJ. Read how Sabine Krummel-Mihajlovic鈥檚 dedicated role improved the employee engagement level of Mahwah employees from 48% to 57% in less than a year.

Financials

听 听 听
11/8/2012 Stryker announces the appointment of David K. Floyd to the role of Group President, Orthopaedics, effective November 15, 2012. Orthopaedics includes the Company's Reconstructive, Trauma and Extremities, Joint Preservation, Orthobiologics and Performance Solutions businesses. Mr. Floyd will report to Kevin A. Lobo, President and Chief Executive Officer of Stryker.
7/6/2012 Stryker has voluntarily recalled its Rejuvenate and ABG II modular-neck stems.听听 Modular-neck stems provide surgeons with an option to correct certain aspects of a patient's anatomy and hip biomechanics, but given the potential risks associated with fretting and corrosion at the modular neck junction, Stryker Orthopaedics decided to take this voluntary action. 听